Phase 1CompletedINTERVENTIONAL
A Study to Test How BI 456906 is Taken up in the Blood of People With and Without Kidney Problems
ClinicalTrials.gov · NCT06352411 · Registry updated: 2026-03-13
- Condition / research focus
- Healthy; Renal Impairment
- Sponsor
- Boehringer Ingelheim
- Countries with listed sites
- Germany
- Registry dates and results
- Start: 2024-05-15. Completion: 2025-09-16 (may be estimated). No results posted in this registry response.
Products and interventions (1)
Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.
- BI 456906 (combination_product) — also listed as: survodutide
Where the study takes place — 2 listed sites
Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.
- CRS Clinical Research Services Kiel GmbH
Kiel, Germany
Site recruitment: Not reported - CRS Clinical Research Services Mannheim GmbH
Mannheim, Germany
Site recruitment: Not reported